Orbimed Advisors LLC 9 Meters Biopharma, Inc. Transaction History

Orbimed Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.26 - $0.64 $460,241 - $1.13 Million	-1,770,158 Reduced 17.23%	8,505,729 $2.22 Million
Q4 2021 Feb 14, 2022	BUY	$0.85 - $1.33 $1.45 Million - $2.27 Million	1,709,913 Added 19.96%	10,275,887 $10.1 Million
Q2 2021 Aug 16, 2021	SELL	$1.04 - $1.5 $17.8 Million - $25.7 Million	-17,150,781 Reduced 66.69%	8,565,974 $9.42 Million
Q2 2020 Aug 14, 2020	BUY	$0.43 - $0.74 $11.1 Million - $19 Million	25,716,755 New	25,716,755 $14.6 Million

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.